BioCentury
ARTICLE | Clinical News

MAP4343 regulatory update

March 24, 2008 7:00 AM UTC

EMEA granted Orphan Drug designation for Mapreg's MAP4343 to treat spinal cord injury. The injectable neurosteroid derivative, which targets microtubule associated protein type 2 ( MAP2), will begin P...